T-cell lymphomas: murine models, in-situ treatments & screening for HTLV1

Francine Foss, MD, of Yale University School of Medicine, New Haven, CT, is joined by Laurence de Leval, MD, PhD, of the University Hospital of Lausanne, Lausanne, Switzerland, David Weinstock, MD, of the Dana-Farber Cancer Institute, Boston, MA, and Lucy Cook, MB BS, PhD, MRCP, FRCPath, of Imperial College Healthcare NHS Trust, London, UK in a discussion on T-cell lymphomas. The defining of vulnerabilities, new targets, the TCR signalling pathway and more is discussed by the experts. This interview was recorded at the 17th International Workshop on Non-Hodgkin Lymphoma held in Boston, MA.